Successful prevention of recurrent ventricular fibrillation by intravenous isoproterenol in a patient with Brugada syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 8, 2001, Pages 1293-1294

  Tanaka, Hirokazu ^a   Kinoshita, Osamu ^a   Uchikawa, Shinichirou ^a   Kasai, Hiroki ^a   Nakamura, Megumi ^a   Izawa, Atsushi ^a   Yokoseki, Osamu ^a   Kitabayashi, Hiroshi ^a   Takahashi, Wataru ^a   Yazaki, Yoshikazu ^a   Watanabe, Noboru ^a   Imamura, Hiroshi ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brugada syndrome; Isoproterenol; Ventricular fibrillation

Indexed keywords

AMIODARONE; DISOPYRAMIDE; ISOPRENALINE; LIDOCAINE; MAGNESIUM SULFATE; MEXILETINE; PROPRANOLOL;

ADULT; ARTICLE; AUTONOMIC INNERVATION; BRUGADA SYNDROME; CASE REPORT; CLINICAL FEATURE; DEFIBRILLATOR; DISEASE COURSE; DRUG EFFECT; ELECTROCARDIOGRAM; EPICARDIUM; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTATION; INFUSION; MALE; PATHOPHYSIOLOGY; ST SEGMENT; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0034884834     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.01293.x     Document Type: Article

References (4)

1. "Brugada" syndrome: Clinical data and suggested pathophysiological mechanism
2. The Brugada syndrome: Clinical, electrophysiologic and genetic aspects
3. The Brugada syndrome
4. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation